Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
107.7 USD | +0.76% | +0.38% | -2.16% |
12:29am | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
12:21am | Edwards Lifesciences first-quarter profit beats estimates on heart devices strength | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.16% | 185B | |
-3.32% | 105B | |
-4.68% | 66.59B | |
+1.60% | 54.66B | |
+17.21% | 47.78B | |
+4.06% | 41.26B | |
+3.07% | 26.95B | |
+2.25% | 26.37B | |
+12.96% | 24.8B | |
-1.72% | 24.6B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Abbott Laboratories : Barclays Adjusts Abbott Laboratories' Price Target to $125 From $150, Maintains Overweight Rating